热门资讯> 正文
据称，Blackstone、TPG即将收购Hologic超过170亿美元
2025-10-19 02:41
- 黑石(BX) 0
- TPG, Inc.(TPG) 0
- 豪洛捷(HOLX) 0
- Private equity firms Blackstone (NYSE:BX) and TPG (NASDAQ:TPG) are in late-stage talks to acquire Hologic (NASDAQ:HOLX) in a transaction that could value the cancer test maker at more than $17B, including debt, Bloomberg News reported, citing people familiar with the matter.
- The companies are currently negotiating a price target of over $75 per share, the people said, adding that a deal could be announced in the coming days.
- Shares of Hologic (NASDAQ:HOLX) closed higher on Thursday after 9fin reported about a $9B financing arrangement to fund the duo’s plans to acquire the Marlborough, Massachusetts-based medical device maker. The stock added another ~2% on Friday and ~6% in the post-market after Bloomberg reported about the potential deal.
- A final agreement has yet to be reached, and the talks could still end prematurely, the people said.
More on Hologic, Blackstone, etc.
- Blackstone Is A Sell Again, At Today's Lofty Valuation
- Blackstone Is A Conundrum (Technical Analysis)
- Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Hologic ticks higher amid report on financing for potential takeover
- Blackstone launches business unit focusing on defined contribution plans
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
